David Jeffs - 29 Dec 2023 Form 4 Insider Report for Cell MedX Corp. (STME)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: STME
Reported as of: 29 Dec 2023
Net transaction value: +$622,718
SEC form: 4
Accepted by SEC: 10 Jan 2024, 13:10:32 UTC
Prior SEC filing: 09 Jan 2024
Source filing: View source filing
Reporting owner signature: David Jeffs

Key filing fact

David Jeffs filed Form 4 for Cell MedX Corp. (STME) on 10 Jan 2024.

Key facts

This page summarizes David Jeffs's Form 4 filing for Cell MedX Corp. (STME).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Jan 2024, 13:10.

Change

Previous filing in this sequence was filed on 09 Jan 2024.
Current net transaction value: +$622,718.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMXC transaction

Common Shares

Award

Transaction value: $517,718
Shares: +73,959,726
Change %
Price: $0.007000^*
Shares after: 73,959,726
Date: 29 Dec 2023
Ownership: Direct
Footnotes: F1

CMXC transaction

Common Shares

Purchase

Transaction value: $52,500
Shares: +7,500,000
Change %: +10%
Price: $0.007000^*
Shares after: 81,459,726
Date: 29 Dec 2023
Ownership: Daughter
Footnotes: F2

CMXC transaction

Common Shares

Purchase

Transaction value: $52,500
Shares: +7,500,000
Change %: +9.2%
Price: $0.007000^*
Shares after: 88,959,726
Date: 29 Dec 2023
Ownership: Son
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

(1) Reporting Person acquired 73,959,726 shares on settlement of $517,718 owed by the Issuer to the Reporting Person.

Footnote F2

Immediate family members of the Reporting Person acquired a total of 15,000,000 shares on settlement of $105,000 owed by the Issuer to the immediate family members. The inclusion of these shares shall not be deemed an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.